scorecardresearch
Add as a preferred source on Google
Sunday, November 30, 2025
TopicVaccine

Topic: Vaccine

Covid vaccine research in India at nascent stage, breakthrough unlikely this year: Experts

At least seven research projects are currently being conducted by Indian pharma companies to develop a vaccine for coronavirus.

Early reports on CanSino’s Covid vaccine say it’s safe, generates an immune response

The report published by The Lancet states the vaccine stimulated production of both antibodies that can stop Covid infection along with immune T-cells.

Oxford, AstraZeneca begin advanced trials of Covid vaccine

The proposed Covid-19 vaccine is made from a weakened version of a common cold virus that’s genetically changed to make it unable to grow in humans.

Ignore hype and euphoria over any Covid vaccine news for next 2-3 months: Adar Poonawalla

At ThePrint's Off The Cuff, Serum Institute of India CEO Adar Poonawalla said efficacy and yields of production can be established only after Phase 3 trials.

Zoya Hasan says fiscal stimulus ‘too little’, Sangh & Modi united on economy says RSS

Today's political, economic & strategic punditry from Rajiv Tuli, Mekhala Krishnamurthy, S Murlidharan & Ashok Jha.

What Moderna didn’t reveal about the first Covid vaccine’s phase 1 trial

Moderna’s press release on its COVID-19 mRNA vaccine trials — called mRNA-1273 — heightened hopes but missed key details.

If I had Covid-19 am I immune? This is what scientists know so far

Based on research so far, it’s reasonable to assume that most people who’ve had Covid-19 are less likely to be re-infected, and less likely to get a severe case if they do.

UK begins trial to see if Hydroxychloroquine prevents Covid-19

The trial will enroll 40,000 healthcare workers across the world and they will be given either hydroxychloroquine or a placebo for three months.

US raises ante in race for coronavirus vaccine with pledge of $1.2 billion to AstraZeneca

President Trump is pushing his way toward the front of the line to secure a shot to protect Americans from the outbreak and allow business to resume.

Drug trial of antiviral Avignan continues in Japan despite inconclusive interim result

China will invest an estimated $1.4 trillion over six years, calling on urban govts & pvt. tech giants to roll out everything from wireless networks to artificial intelligence.

On Camera

‘Delhi winters’ is a legend. Now it’s just air anxiety

The wealthy float above the crisis—insulated in air-purified cars, weekend getaways at farmhouses, and vacations timed perfectly to coincide with Delhi’s worst weeks.

Karnataka startups feel the chill as global funding winter sets in. Fintech emerges as sole bright spot

The state raises just $2.7 billion in first nine months of 2025 compared to $4.5 billion last year, with late-stage investments hit hardest.

What’s expected from Putin’s India visit in December—Defence Secretary explains

ThePrint had previously reported that India & Russia are talking about 5 more regiments of the S-400, but no contracts are to be signed during the Russian president's visit.

Gaali cricket: Bavuma stands tall, India’s Test ego cut to size

The India-South Africa series-defining fact is the catastrophic decline of Indian red ball cricket where a visiting team can mock us with the 'grovel' word.